For those struggling with traditional diet and exercise plans, tirzepatide may be the breakthrough treatment you've been searching for
Twin is already trusted by leading employers to treat cardiometabolic disease without long-term dependence on high-cost medications: "At Medline, we focus on long-term metabolic health by addressing root causes like insulin resistance, inflammation, and overall cardiometabolic risk," said Angela Sim, Vice President of Benefits at Medline
The error conflates two different concepts: Off-label prescribing (legal and common): A provider prescribes an FDA-approved medication for a use not listed on the label
Specifically: Self-funded large-employer plans are more likely to cover Wegovy Small-group commercial plans coverage varies dramatically Marketplace ACA plans typically don't cover obesity-specific GLP-1s Medicare Part D coverage for weight-loss-only is rare
So actually, I was thinking Id become an endocrinologist or a diabetologist